Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evogene Q1 2024 GAAP EPS $(0.08) Beats $(0.09) Estimate, Sales $4.190M Beat $3.500M Estimate

Author: Benzinga Newsdesk | May 23, 2024 07:11am

Posted In: EVGN